BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 27813494)

  • 1. Differentially expressed miRNAs in triple negative breast cancer between African-American and non-Hispanic white women.
    Sugita B; Gill M; Mahajan A; Duttargi A; Kirolikar S; Almeida R; Regis K; Oluwasanmi OL; Marchi F; Marian C; Makambi K; Kallakury B; Sheahan L; Cavalli IJ; Ribeiro EM; Madhavan S; Boca S; Gusev Y; Cavalli LR
    Oncotarget; 2016 Nov; 7(48):79274-79291. PubMed ID: 27813494
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A panel of miRNAs as prognostic markers for African-American patients with triple negative breast cancer.
    Turkistani S; Sugita BM; Fadda P; Marchi R; Afsari A; Naab T; Apprey V; Copeland RL; Campbell MC; Cavalli LR; Kanaan Y
    BMC Cancer; 2021 Jul; 21(1):861. PubMed ID: 34315420
    [TBL] [Abstract][Full Text] [Related]  

  • 3. QNBC Is Associated with High Genomic Instability Characterized by Copy Number Alterations and miRNA Deregulation.
    Bhattarai S; Sugita BM; Bortoletto SM; Fonseca AS; Cavalli LR; Aneja R
    Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34768979
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integrated copy number and miRNA expression analysis in triple negative breast cancer of Latin American patients.
    Sugita BM; Pereira SR; de Almeida RC; Gill M; Mahajan A; Duttargi A; Kirolikar S; Fadda P; de Lima RS; Urban CA; Makambi K; Madhavan S; Boca SM; Gusev Y; Cavalli IJ; Ribeiro EMSF; Cavalli LR
    Oncotarget; 2019 Oct; 10(58):6184-6203. PubMed ID: 31692930
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcome disparities in African American women with triple negative breast cancer: a comparison of epidemiological and molecular factors between African American and Caucasian women with triple negative breast cancer.
    Sturtz LA; Melley J; Mamula K; Shriver CD; Ellsworth RE
    BMC Cancer; 2014 Feb; 14():62. PubMed ID: 24495414
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential expression of microRNA between triple negative breast cancer patients of African American and European American descent.
    MacCuaig WM; Thomas A; Claros-Sorto JC; Gomez-Gutierrez JG; Alexander AC; Wellberg EA; Grizzle WE; McNally LR
    Biotech Histochem; 2022 Jan; 97(1):1-10. PubMed ID: 34979848
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Somatic mutations of triple-negative breast cancer: a comparison between Black and White women.
    Omilian AR; Wei L; Hong CC; Bandera EV; Liu S; Khoury T; Ambrosone CB; Yao S
    Breast Cancer Res Treat; 2020 Jul; 182(2):503-509. PubMed ID: 32441016
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the Genomic Landscape Between Primary Breast Cancer in African American Versus White Women and the Association of Racial Differences With Tumor Recurrence.
    Keenan T; Moy B; Mroz EA; Ross K; Niemierko A; Rocco JW; Isakoff S; Ellisen LW; Bardia A
    J Clin Oncol; 2015 Nov; 33(31):3621-7. PubMed ID: 26371147
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential methylation and expression patterns of microRNAs in relation to breast cancer subtypes among American women of African and European ancestry.
    Gong Z; Chen J; Wang J; Liu S; Ambrosone CB; Higgins MJ
    PLoS One; 2021; 16(3):e0249229. PubMed ID: 33784351
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Race Disparities in the Contribution of miRNA Isoforms and tRNA-Derived Fragments to Triple-Negative Breast Cancer.
    Telonis AG; Rigoutsos I
    Cancer Res; 2018 Mar; 78(5):1140-1154. PubMed ID: 29229607
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Racial Disparities in Triple Negative Breast Cancer: A Review of the Role of Biologic and Non-biologic Factors.
    Prakash O; Hossain F; Danos D; Lassak A; Scribner R; Miele L
    Front Public Health; 2020; 8():576964. PubMed ID: 33415093
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genome-wide copy number alterations in subtypes of invasive breast cancers in young white and African American women.
    Loo LW; Wang Y; Flynn EM; Lund MJ; Bowles EJ; Buist DS; Liff JM; Flagg EW; Coates RJ; Eley JW; Hsu L; Porter PL
    Breast Cancer Res Treat; 2011 May; 127(1):297-308. PubMed ID: 21264507
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differences in the mutational landscape of triple-negative breast cancer in African Americans and Caucasians.
    Ademuyiwa FO; Tao Y; Luo J; Weilbaecher K; Ma CX
    Breast Cancer Res Treat; 2017 Feb; 161(3):491-499. PubMed ID: 27915434
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deregulated miRNA Expression in Triple-Negative Breast Cancer of Ancestral Genomic-Characterized Latina Patients.
    Almohaywi M; Sugita BM; Centa A; Fonseca AS; Antunes VC; Fadda P; Mannion CM; Abijo T; Goldberg SL; Campbell MC; Copeland RL; Kanaan Y; Cavalli LR
    Int J Mol Sci; 2023 Aug; 24(17):. PubMed ID: 37685851
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epigenetic Profiles of Triple-Negative Breast Cancers of African American and White Females.
    Ensenyat-Mendez M; Solivellas-Pieras M; Llinàs-Arias P; Íñiguez-Muñoz S; Baker JL; Marzese DM; DiNome ML
    JAMA Netw Open; 2023 Oct; 6(10):e2335821. PubMed ID: 37796506
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genomic analysis of racial differences in triple negative breast cancer.
    Chang CS; Kitamura E; Johnson J; Bollag R; Hawthorn L
    Genomics; 2019 Dec; 111(6):1529-1542. PubMed ID: 30366040
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early-onset triple-negative breast cancer in multiracial/ethnic populations: Distinct trends of prevalence of truncation mutations.
    Liu Q; Yao S; Zhao H; Hu Q; Kwan ML; Roh JM; Ambrosone CB; Kushi LH; Liu S; Zhu Q
    Cancer Med; 2019 Apr; 8(4):1845-1853. PubMed ID: 30864286
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The persisting puzzle of racial disparity in triple negative breast cancer: looking through a new lens.
    Garlapati C; Joshi S; Sahoo B; Kapoor S; Aneja R
    Front Biosci (Schol Ed); 2019 Mar; 11(1):75-88. PubMed ID: 30844737
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Androgen Receptor and ALDH1 Expression Among Internationally Diverse Patient Populations.
    Jiagge E; Jibril AS; Davis M; Murga-Zamalloa C; Kleer CG; Gyan K; Divine G; Hoenerhoff M; Bensenhave J; Awuah B; Oppong J; Adjei E; Salem B; Toy K; Merajver S; Wicha M; Newman L
    J Glob Oncol; 2018 Oct; 4():1-8. PubMed ID: 30307804
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic Ancestry using Mitochondrial DNA in patients with Triple-negative breast cancer (GAMiT study).
    Rao R; Rivers A; Rahimi A; Wooldridge R; Rao M; Leitch M; Euhus D; Haley BB
    Cancer; 2017 Jan; 123(1):107-113. PubMed ID: 27584945
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.